R. Kim Brazzell's most recent trade in Kala Pharmaceuticals Inc was a trade of 5,251 Common Stock done at an average price of $4.0 . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 24 Jun 2025 | 5,251 | 82,698 (0%) | 0% | 4.0 | 21,057 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 03 Jun 2025 | 3,687 | 87,949 (0%) | 0% | 3.7 | 13,789 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 45,200 | 45,200 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,100 | 94,864 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 7.63 per share. | 06 Jan 2025 | 2,446 | 92,418 (0%) | 0% | 7.6 | 18,663 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 26 Jun 2024 | 5,489 | 83,982 (0%) | 0% | 4.8 | 26,073 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.09 per share. | 31 May 2024 | 2,002 | 89,471 (0%) | 0% | 6.1 | 12,192 | Common Stock |
| Kala Pharmaceuticals Inc | Kim Brazzell R. | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 29,300 | 29,300 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Kim Brazzell R. | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 6,500 | 93,090 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Brazzell Kim R. | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 04 Jan 2024 | 1,617 | 91,473 (0%) | 0% | 6.7 | 10,899 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 576 | 576 | - | - | Stock Option (Right to Buy) | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 12,800 | 18,609 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 28.53 per share. | 04 Jan 2023 | 73 | 18,536 (0%) | 0% | 28.5 | 2,083 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.51 per share. | 26 Oct 2022 | 261 | 5,809 (0%) | 0% | 6.5 | 1,699 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 27 Jun 2022 | 3,144 | 285,201 (0%) | 0% | 0.4 | 1,163 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 238,000 | 238,000 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 03 Jan 2022 | 3,504 | 288,345 (0%) | 0% | 1.3 | 4,555 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 26 Oct 2021 | 12,757 | 291,849 (0%) | 0% | 1.8 | 22,963 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.77 per share. | 28 Jun 2021 | 3,034 | 300,962 (0%) | 0% | 5.8 | 17,506 | Common Stock |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 27,500 | 303,996 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2020 | 81,000 | 276,496 (0%) | 0% | 0 | Common Stock |